Covered recipient · General Payments record
JOSHUA JEDWAB
Allopathic & Osteopathic Physicians Anesthesiology
General Payments · PY2018–2022
$4,084.49
- Reported across 324 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $220.34 | 20 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $144.86 | 17 |
| Janssen Biotech, Inc. | $37.56 | 1 |
| RedHill Biopharma Inc. | $22.64 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.65 | 01/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930319 | CMS |
| ABBVIE INC. | $22.19 | 01/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930323 | CMS |
| ABBVIE INC. | $23.52 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930325 | CMS |
| ABBVIE INC. | $3.73 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930329 | CMS |
| ABBVIE INC. | $2.85 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930333 | CMS |
| ABBVIE INC. | $13.77 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930337 | CMS |
| ABBVIE INC. | $2.62 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930341 | CMS |
| ABBVIE INC. | $21.71 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930345 | CMS |
| ABBVIE INC. | $0.83 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930349 | CMS |
| ABBVIE INC. | $0.67 | 03/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930353 | CMS |
| ABBVIE INC. | $17.51 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930357 | CMS |
| ABBVIE INC. | $2.92 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930361 | CMS |
| ABBVIE INC. | $2.02 | 06/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930365 | CMS |
| ABBVIE INC. | $2.27 | 07/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930369 | CMS |
| ABBVIE INC. | $0.68 | 07/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930373 | CMS |
| ABBVIE INC. | $20.82 | 07/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930377 | CMS |
| ABBVIE INC. | $4.10 | 10/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892930381 | CMS |
| Janssen Biotech, Inc. | $37.56 | 02/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886245325 | CMS |
| RedHill Biopharma Inc. | $22.64 | 01/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 902946145 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.28 | 08/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 959932691 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.